NEWSMAKERS

Veracyte Announces Big Developments

Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew significantly. Percepta Gets Thumbs Up … [Read more...]

NEWS

Diagnostic Deals: A Roundup of February’s Mergers, Acquisitions, Alliances, Licenses and Other Major Transactions

After January's flurry of deals, the M&A front has been relatively quiet so far this month. But relatively low volume of M&A deals has been more than offset by surges in strategic alliances … [Read more...]

NEWS

Industry Newsmaker: Veracyte, Inc. Scores Big with Percepta and Affirma GEC

Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew significantly. Percepta Gets Thumbs Up … [Read more...]

NEWS

FDA Watch: Discussion Paper Signals New Approach (Not Retreat) to LDT Regulation

After nearly two years of inactivity, things are suddenly heating up on FDA regulation of laboratory developed tests (LDTs). As promised, the agency took action on LDTs by the end of 2016—but not in … [Read more...]

NEWS

Diagnostic Deals: A Roundup of January’s Mergers, Acquisitions, Alliances, Licenses and Other Major Transactions

January 2017 has already seen an unusually high volume of diagnostic deal making. Here is a quick overview of the key deals and what they portend. M&A While Abbott Laboratories made the … [Read more...]

NEWS

FDA Watch: Next-Gen Sequencing Companion Test Wins Approval

Last month, the U.S. Food and Drug Administration shelved its longawaited/ dreaded (depending on your point of view) final guidance on laboratory-developed tests. (For the details, see, LIR, Nov. … [Read more...]


(-00000g2)